SCHEMBL2015774

SCHEMBL2015774

CC(C)OC(=O)[C@H](Cc1ccccc1)NF

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
ALDH1A1 P00352 2/20 0.49
THRB P10828 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
HSD17B10 Q99714 1/20 0.49
ATM Q13315 1/20 0.47
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
CA12 O43570 1/20 0.46
CA2 P00918 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
POLB P06746 1/20 0.45
GAA P10253 1/20 0.44
ACE P12821 1/20 0.44
LMNA P02545 2/20 0.43
GLA P06280 1/20 0.43
TACR1 P25103 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015772 1.00 TSHR (0.50) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL27556826 0.86 TSHR (0.51) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL6803690 0.86 TSHR (0.51) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL25100758 0.86 TSHR (0.51) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL20239092 0.85 ATM (0.61) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL20239093 0.85 ATM (0.61) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL15497675 0.84 TSHR (0.50) TSHRALDH1A1THRBCYP2C9CYP2C19
Hydrochloric Acid SCHEMBL27714985 0.84 ATM (0.60) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
Hydrochloric Acid SCHEMBL27714987 0.84 ATM (0.60) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL5813004 0.83 TACR1 (0.61) ALDH1A1THRBCYP2C9CYP2C19HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011078782-A1 A COMPOSITION COMPRISING OF MELPHALAN DERIVATIVES AND GEMCITABINE OR ETOPOSIDE USEFUL IN THE TREATMENT OF CANCER ONCOPEPTIDES AB (SE) 2011-06-30 WO claimed
CN-108096563-A The lyophilized formulations of cytotoxicity dipeptides 肿瘤多肽股份公司 2018-06-01 CN disclosed
WO-2011078782-A1 A COMPOSITION COMPRISING OF MELPHALAN DERIVATIVES AND GEMCITABINE OR ETOPOSIDE USEFUL IN THE TREATMENT OF CANCER ONCOPEPTIDES AB (SE) 2011-06-30 WO disclosed